Bixiye
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2201 - 2210 ee natiijooyinka 3289
Bixiye
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP77-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective December 1, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP78-21 Commercial Pharmacy Benefit Update – New Drug-Related Quantity Limit (QL) Criteria: Stromectol® (ivermectin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP79-21 New Availity Appeal Portal Available to Create, Submit and Inquire on Post Service Claim Appeals
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
P53-21 Update for New-to-Market Medical Drug: aducanumab (Aduhelm)
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
2021 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P58-21 2022 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P54-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021